Firearm-related hospitalizations had dropped before the pandemic, then shot up, study finds
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Apr-2025 08:08 ET (26-Apr-2025 12:08 GMT/UTC)
Firearm injuries that sent victims to the hospital had gone down steadily over the five years before the COVID-19 pandemic began, but reversed course sharply over the next two years, a new University of Michigan study finds.
A study by the Università Cattolica, Rome campus - Fondazione Policlinico Universitario A. Gemelli IRCCS and the Ospedale Pediatrico Bambino Gesù IRCCS, published in the Nature Group journal ‘Pediatric Research’, identifies the ‘protein signature’ of the condition in plasma, a group of pro-inflammatory molecules present at high concentrations in young patients with the condition. An Artificial Intelligence (AI) tool makes the diagnosis based on the results of the blood sample.
Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses. Scientists believe key immune elements – cells and genes – may explain resolution versus progression of the disease.
Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with no major changes in symptom clusters during the second year of their illness, according to a new study published January 23rd in the open-access journal PLOS Medicine by Winfried Kern of Freiburg University, Germany, and colleagues.
While child deaths in England fell temporarily during the COVID-19 pandemic, they have now risen to new heights, a new study from researchers at the University of Bristol and based on unique National Child Mortality Database (NCMD) data has found.
A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.
Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood and other fluids from patients with acute COVID-19 infections, creating the potential for guiding future treatment of patients. The research is published in Science Advances.